ARCHIVES

IL-2 Trials Proliferate; Biotherapeutics Sees NCI Proposal As Vindication Of Its Policies

This article is from The Cancer Letter archive.

Vol. 13 No. 19 | May 8, 1987

Download PDF Visit The Full Archive

Related Articles

Clearinghouse Completes Review of Backlog, Funds What Caused It, Reports On Program Value

May 19, 1978

VEGF Inhibitor Slows Thyroid Cancer Progression In Some Patients, Study Finds

July 25, 2008

FDA Proposes “Clarification” Of Clinical Studies regulations, Including Sanctions, Inspections

August 18, 1978

Robert Young To Step Down As Fox Chase Cancer Center President in 2007.

September 29, 2006

NAS Committee Urges Greater Rewards For Interdisciplinary Research.

January 21, 2005

ASCO Says FDA Plan For ESA Management Will Burden Oncologists

March 5, 2010